Fluticasone Propionate; Salmeterol Xinafoate Powder shortage
To Be DiscontinuedFluticasone Propionate; Salmeterol Xinafoate Powder is currently listed as To Be Discontinued in the FDA Drug Shortage Database. Reported reason: Not specified.
Therapeutic category
Dosage form
Powder
Routes
RESPIRATORY (INHALATION)
Last updated
06/13/2025
Strength variants
- Not specified
Need sourcing help for Fluticasone Propionate; Salmeterol Xinafoate Powder?
Get connected with licensed distributors and 503B compounders that can fulfill orders during active shortages. Verified suppliers, no spam.
Connect with a sourcing partnerManufacturers reporting shortage
- Teva Pharmaceuticals USA, Inc.800-545-8800To Be Discontinued
- Teva Pharmaceuticals USA, Inc.800-545-8800To Be Discontinued
- Teva Pharmaceuticals USA, Inc.800-545-8800To Be Discontinued
Reason for shortage
ad slot 300x250
Related shortages in Pulmonary/Allergy
Cromolyn Sodium Concentrate
- Category
- Pulmonary/Allergy
- Reason
- Not specified
- Updated
- 04/08/2026
Cromolyn Sodium Concentrate
- Category
- Pulmonary/Allergy
- Reason
- Not specified
- Updated
- 04/01/2026
Cromolyn Sodium Concentrate
- Category
- Pulmonary/Allergy
- Reason
- Not specified
- Updated
- 03/02/2026
Cromolyn Sodium Concentrate
- Category
- Pulmonary/Allergy
- Reason
- Demand increase for the drug
- Updated
- 03/02/2026
Albuterol Sulfate Solution
- Category
- Pulmonary/Allergy
- Reason
- Not specified
- Updated
- 01/07/2026
This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.